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Abstract. 
 
Previous work from our laboratory sug-
gested that microtubules are released from the neu-
ronal centrosome and then transported into the axon 
(Ahmad, F.J., and P.W. Baas. 1995. 
 
J. Cell Sci.
 
 108:
2761–2769). In these studies, cultured sympathetic neu-
rons were treated with nocodazole to depolymerize 
most of their microtubule polymer, rinsed free of the 
drug for a few minutes to permit a burst of microtubule 
assembly from the centrosome, and then exposed to na-
nomolar levels of vinblastine to suppress further micro-
tubule assembly from occurring. Over time, the micro-
tubules appeared first near the centrosome, then 
dispersed throughout the cytoplasm, and finally con-
centrated beneath the periphery of the cell body and 
within developing axons. In the present study, we mi-
croinjected fluorescent tubulin into the neurons at the 
time of the vinblastine treatment. Fluorescent tubulin 
was not detected in the microtubules over the time 
frame of the experiment, confirming that the redistribu-
tion of microtubules observed with the experimental 
regime reflects microtubule transport rather than mi-
crotubule assembly. To determine whether cytoplasmic 
dynein is the motor protein that drives this transport, 
we experimentally increased the levels of the dynamitin 
subunit of dynactin within the neurons. Dynactin, a 
complex of proteins that mediates the interaction of cy-
toplasmic dynein and its cargo, dissociates under these 
conditions, resulting in a cessation of all functions of 
the motor tested to date (Echeverri, C.J., B.M. Paschal, 
K.T. Vaughan, and R.B. Vallee. 1996. 
 
J. Cell Biol.
 
 132:
617–633). In the presence of excess dynamitin, the mi-
crotubules did not show the outward progression but 
instead remained near the centrosome or dispersed 
throughout the cytoplasm. On the basis of these results, 
we conclude that cytoplasmic dynein and dynactin are 
essential for the transport of microtubules from the 
centrosome into the axon.
 
T
 
he
 
 microtubule array of the axon is tightly regu-
lated. Each microtubule within the array is oriented
with its plus end distal to the cell body of the neuron
(Heidemann et al., 1981), and each microtubule has a con-
sistent 13-protofilament lattice (Tilney et al., 1973). In typ-
ical nonneuronal cells, the polarity orientation and lattice
structure of a microtubule are influenced by its nucleation
from and attachment to the centrosome (Euteneuer and
McIntosh, 1982; Brinkley, 1985; Evans et al., 1985). Inter-
estingly, the microtubules within the axon are not attached
to the centrosome and yet are tightly regulated with re-
gard to their polarity orientation and lattice structure. A
possible explanation for this apparent paradox is that mi-
crotubules destined for the axon are in fact nucleated at
the centrosome within the cell body of the neuron, after
which they are released and transported into the axon with
their plus ends leading. In this model, axonal microtubules
obtain their lattice structure from centrosomal nucleation
and their polarity orientation from their specific transport
by a microtubule-based motor protein (for reviews see
Baas, 1996, 1997). Initial support for this model was de-
rived from studies showing that 
 
g
 
-tubulin, a protein essen-
tial for microtubule nucleation within living cells, is absent
from the axon and concentrated at the centrosome within
neurons (Baas and Joshi, 1992), and from studies showing
that experimental inhibition of microtubule nucleation at
the centrosome compromises axon outgrowth (Ahmad et
al., 1994). 
Additional support for the model was derived from
pharmacological studies from our laboratory. These stud-
ies were aimed at resolving the contribution of microtu-
bule transport by suppressing the contribution of microtu-
bule assembly. In one study, we cultured rat sympathetic
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neurons in the presence of various concentrations of vin-
blastine that were shown to prevent the total microtubule
levels in the neurons from increasing as well as individual
microtubules from elongating (Baas and Ahmad, 1993).
Microtubules accumulated within the axons of these neu-
rons and were concomitantly depleted from the cell body,
suggesting a transfer of microtubule from one compart-
ment of the neuron into the other. In all cases, the micro-
tubules appeared within the axons with their plus ends dis-
tal to the cell body, indicating that new microtubule
assembly is not required for the establishment of this pat-
tern. In a subsequent study, we used nocodazole to experi-
mentally deplete the neurons of microtubules and then
rinsed out the drug for a few minutes to permit a burst of
microtubule assembly from the centrosome (Ahmad and
Baas, 1995). We then exposed the neurons to an appropri-
ate concentration of vinblastine to suppress further micro-
tubule assembly from occurring. Over time, there was a
gradual depletion of microtubules from the centrosome
and central region of the cell body and a concomitant ac-
cumulation of microtubules at the periphery of the cell
body and within developing axons. On the basis of these
two studies, we concluded that microtubules are actively
transported from the centrosome into the axon, presum-
ably by a motor protein that conveys them specifically
with their plus ends leading. 
If the observed redistribution of microtubules in our ex-
perimental regime is indeed the result of motor-driven mi-
crotubule transport, it should be possible to identify the
specific motor protein that is responsible. Cytoplasmic
dynein is a potentially attractive candidate. It has the ap-
propriate directionality to transport microtubules with
plus ends leading (Paschal and Vallee, 1987; Holzbaur and
Vallee, 1994) and has already been shown to be capable
of generating forces that may organize microtubules dur-
ing mitotic spindle formation (Heald et al., 1996; see also
McGrail and Hayes, 1997). Abundant evidence suggests that
cytoplasmic dynein transports membranous organelles along
the axon in the retrograde direction (see for example
Schnapp and Reese, 1989). An additional role for cyto-
plasmic dynein in microtubule transport is consistent with
the fact that most of the cytoplasmic dynein that moves
anterogradely down the axon does so in the slow compo-
nent of axonal transport, the component in which the cy-
toskeletal elements move (Dillman et al., 1996
 
a
 
). 
To test whether cytoplasmic dynein is the motor that
transports microtubules from the neuronal centrosome
into the axon, we have now performed the pharmacologi-
cal regime described above on neurons in which we inhib-
ited cytoplasmic dynein function by disrupting dynactin.
Dynactin, a complex of at least nine polypeptides that range
from 24 to 150 kD (Gill et al., 1991; Paschal et al., 1993;
Schafer et al., 1994; Karki and Holzbaur, 1995; Vaughan
and Vallee, 1995), has been implicated in cytoplasmic dy-
nein function in biochemical, genetic, and cell biological
analyses (for reviews see Allan, 1996; Schroer, 1996; Val-
lee and Sheetz, 1996). The 50-kD subunit of dynactin, orig-
inally termed p50, was renamed dynamitin to reflect its ca-
pacity to dissociate the complex when present at high
levels (Echeverri et al., 1996). The dissociation of dynactin
by excess dynamitin disrupts all cytoplasmic dynein-depen-
dent cellular events tested to date in nonneuronal cells, in-
cluding chromosome alignment and spindle organization
during prometaphase (Echeverri et al., 1996), as well as lo-
calization of membranous organelles and organization of
microtubule arrays during interphase (Burkhardt et al.,
1997). Our studies now show that microinjection of recom-
binant dynamitin into cultured neurons inhibits axon out-
growth and prevents the outward progression of microtu-
bules observed with the pharmacological regime. On the
basis of these results, we conclude that cytoplasmic dynein
and dynactin are necessary for the transport of microtu-
bules from the neuronal centrosome into the axon.
 
Materials and Methods
 
Cell Culture
 
Cultures of sympathetic neurons from the superior cervical ganglia of
newborn rat pups were prepared as follows. After dissection, the ganglia
were treated with 0.25% collagenase and 0.25% trypsin for 15 min and
then triturated with a Pasteur pipet into a single cell dispersion. The cells
were then plated onto “special dishes” that were prepared by adhering a
glass coverslip to the bottom of a 35-mm plastic petri dish into which had
been drilled a 1-cm-diam hole. For the preparation of these dishes, we
used glass coverslips that had been photoetched with a pattern of demar-
cated boxes that assist in the relocation of individual cells (Bellco Glass,
Inc., Vineland, NJ). Before plating the cells, the glass-bottomed well of
the special dish was treated for 3 h with 1 mg/ml polylysine, rinsed exten-
sively, and then treated with 10 
 
m
 
g/ml laminin (Sigma Chemical Co., St.
Louis, MO) for 4 h. Cells were plated in medium consisting of Leibovitz’
L-15 (Sigma Chemical Co.) supplemented with 0.6% glucose, 2 mM 
 
l
 
-gluta-
mine, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, 10% fetal bovine serum
(Hyclone Labs, Logan, UT), and 100 ng/ml nerve growth factor (Upstate
Biotechnology, Lake Placid, NY).
 
Pharmacological Regime for Revealing
Microtubule Transport
 
In a previous report, we described a pharmacological regime for revealing
the transport of microtubules from the centrosome first to the periphery
of the neuronal cell body and then into developing axons (Ahmad and
Baas, 1995; see introduction). In this regime, nocodazole (Aldrich Chemi-
cal Co., Milwaukee, WI) was introduced into the cultures 30 min after
plating at a final concentration of 10 
 
m
 
g/ml, and the cultures were re-
turned to the incubator. After 6 h, the cultures were rinsed twice with
warm drug-free medium, placed in a third rinse of warm drug-free me-
dium, and then returned to the incubator. After 3 min of recovery, vin-
blastine sulfate (Sigma Chemical Co.) was added to a final concentration
of 50 nM, and the cultures were once again returned to the incubator for
various periods of time. Cultures were then prepared for immunofluores-
cence visualization of microtubule distribution at various points during
this regime. In the present study, we wished to confirm that the relocation
of microtubules observed with this regime is truly the result of microtu-
bule transport rather than of new microtubule assembly that might have
occurred even in the presence of the drug. To resolve this issue, we intro-
duced fluorescent (rhodamine-labeled) tubulin into the neuron concomi-
tantly with the addition of the vinblastine. By “concomitantly,” we mean
that the vinblastine was added first, and then two to three cells per dish
were rapidly injected. Most cells were injected within 3 s of the addition of
the drug, and no cells were injected at times greater than 3 min. The fluo-
rescent tubulin was prepared as described by Keating et al. (1997) and was
injected at a concentration of 4 mg/ml and a volume of roughly 0.1 picoli-
ters. After 30 min, sufficient time for the microtubules to vacate the cen-
tral region of the cell body and accumulate at cell periphery, the cultures
were extracted, fixed, and prepared for immunofluorescence microscopy
so that an image of the total microtubule mass within the cell could be vi-
sualized side-by-side with an image of any fluorescent tubulin that had in-
corporated into polymer during the vinblastine treatment.
 
Preparation of Bacterially Expressed Dynamitin
 
Bacterial expression of human dynamitin protein was carried out using the
pET14b system (Novagen, Madison, WI) as previously described (Echev- 
Ahmad et al. 
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erri et al., 1996). Recombinant protein was purified by one of two meth-
ods, both of which gave similar results. In the first method, the recombi-
nant protein was expressed with a thrombin-cleavable His-tag at its NH
 
2
 
terminus. Nickel-affinity purification and subsequent removal of the His-
tag were carried out with a commercially available kit according to the
manufacturer’s instructions (Novagen). In the other method, the recombi-
nant protein was expressed without the His-tag and was purified by
MonoQ ion-exchange chromatography, followed by size fractionation us-
ing gel filtration chromatography (see Whitman et al., 1997). If necessary,
the protein obtained with either of these methods was then concentrated
either by using Centricon-30 concentrators (Amicon, Beverly, MA) or by
a salt bump from a MonoQ column on the SMART system. The protein
was aliquoted and then frozen in liquid nitrogen at a final concentration of
3 mg/ml in a buffer containing 50 mM Kpipes, pH 7.0, 100 mM KCl, 1 mM
EGTA, 0.1% BME, and 10% glyclerol. This buffer showed no deleterious
effects on the health of a number of different cell types, including primary
rat sympathetic neurons, when microinjected into their cytoplasm. The al-
iquots were thawed just before use, and the protein was microinjected
without further dilution at a volume of roughly 0.1 picoliters per cell. Mi-
croinjection was carried out on the environmentally regulated stage of an
inverted microscope using the Eppendorf (Hamburg, Germany) microin-
jection system. The purity of the recombinant protein was confirmed by
SDS-PAGE.
 
Experimental Regimes Involving
Recombinant Dynamitin
 
Three experimental regimes involving recombinant dynamitin were used.
First, we wanted to confirm that microinjection of recombinant dynamitin
effectively inactivates a known function of cytoplasmic dynein and that
this response is not obtained if the protein is denatured by boiling before
microinjection. For this, we examined the distribution of Golgi elements,
reported to be regulated by cytoplasmic dynein (Corthesy-Theulaz et al.,
1992; Fath et al., 1994; Burkhardt et al., 1997), in uninjected cells, cells that
had been microinjected with the recombinant protein, and cells that had
been microinjected with the recombinant protein after boiling. Second,
having confirmed the usefulness of the recombinant dynamitin as a tool
for studying cytoplasmic dynein function, we wished to use it to ascertain
the effects of inactivating cytoplasmic dynein on axon outgrowth. For this,
we microinjected either the viable or denatured dynamitin protein into
freshly plated neurons that had been permitted to attach to the glass cov-
erslip for roughly 30 min. The cells were then monitored over time and the
extent of axon outgrowth was recorded using either a thermal video-
printer (Sony, Japan) or a cooled CCD (Photometrics, Tucson, AZ) to ob-
tain higher resolution images. Axon outgrowth per cell was measured as
the sum of the length of all axons extended by an individual neuron.
Third, we investigated the potential role of cytoplasmic dynein in trans-
porting microtubules outward from the neuronal centrosome using a mod-
ification of the pharmacological regime described above (Ahmad and
Baas, 1995). For this, either the native or denatured dynamitin protein
was microinjected into a portion of the neurons in the dish after the fifth
hour in nocodazole.
 
Fluorescence Microscopy
 
For visualization of Golgi elements, we used a modification of the proce-
dure of Letourneau and Wire (1995). Cultures were fixed and extracted
simultaneously for 15 min in a microtubule-stabilizing buffer termed
PHEM (60 mM Pipes, 25 mM Hepes, 10 mM EGTA, 2 mM MgCl
 
2
 
, pH
6.9) containing 0.2% glutaraldehyde and 0.1% Triton X-100, rinsed in
PHEM, treated for 15 min with 10 mg/ml sodium borohydride to reduce
autofluorescence, incubated for 15 min in a blocking solution containing 5
mg/ml BSA in PBS, incubated for 1 h at 37
 
8
 
C with 75 
 
m
 
g/ml rhodamine-
conjugated wheat germ agglutinin (Sigma Chemical Co.), rinsed in PBS,
and mounted in a medium containing 100 mg/ml DABCO and 1 mg/ml
 
p
 
-phenylenediamine in 90% glycerol and 10% PBS (to reduce photobleach-
ing).
For visualization of microtubules, we used our previously described pro-
cedure (Ahmad and Baas, 1995). Cultures were rinsed briefly in PHEM
and then extracted for 3 min with 0.5% Triton X-100 in PHEM containing
10 
 
m
 
M taxol (provided as a gift from the National Cancer Institute, Be-
thesda, MD). This treatment removes unassembled tubulin while preserv-
ing microtubules (Black et al., 1986). The cultures were then fixed by the
addition of an equal volume of PHEM containing 8% paraformaldehyde
and 0.3% glutaraldehyde. After 10 min of fixation, the cultures were
rinsed twice in PBS, treated three times for 5 min each in PBS containing
10 mg/ml sodium borohydride, and rinsed again in PBS. Cultures were
then treated for 30 min in a blocking solution containing 2% normal goat
serum and 1% BSA in PBS and exposed overnight at 4
 
8
 
C to the primary
antibody diluted in blocking solution. The following morning, the cultures
were rinsed three times in PBS, treated again for 30 min in blocking solu-
tion, exposed for 1 h at 37
 
8
 
C to the second antibody diluted in blocking so-
lution, rinsed four times for 5 min each in PBS, and mounted in the same
mounting medium described above for the Golgi studies. The primary an-
tibody was a mouse monoclonal antibody against 
 
b
 
-tubulin used at 1:500
and purchased from Amersham Corp. (Arlington Heights, IL). For the
studies on cells into which rhodamine-labeled tubulin had been injected,
the second antibody was a fluorescein-conjugated goat anti–mouse used at
1:100. For all other experiments, the second antibody was a Cy-3–conju-
gated goat anti–mouse used at 1:100. Both second antibodies were pur-
chased from Jackson ImmunoResearch (West Grove, PA).
For the studies on fluorescent-tubulin incorporation, the cells were vi-
sualized with a cooled CCD to optimize sensitivity and improve our ability
to visualize any incorporation of fluorescent tubulin into microtubules
that might have occurred. For all other studies, a confocal microscope was
used to optimize resolution. Optical sections through each cell were ob-
tained using the LSM 410 laser scanning confocal microscope (Carl Zeiss,
Inc., Thornwood, NY). The optical sections were 0.5 
 
m
 
m in width, and all
sections composing an individual cell were examined. Estimates of total
microtubule levels within individual neurons were routinely obtained us-
ing either the Zeiss system software or NIH Image software (provided
free of charge from the National Institutes of Health, Bethesda, MD) to
confirm the efficacy of the vinblastine treatment.
 
Results
 
The Pharmacological Regime Reveals
Microtubule Transport
 
In a previous report, we described the following experi-
mental regime, summarized in Fig. 1 (see Ahmad and
Baas, 1995). Freshly plated rat sympathetic neurons are
treated for 6 h with nocodazole, which typically diminishes
their microtubule mass to less than 1% of control levels
(the drug is less effective in 
 
z
 
10% of the cells). The drug is
then rinsed out, and microtubules are permitted to reas-
semble for 3 min. Virtually all of the microtubules reas-
semble from the centrosome, and these microtubules are
typically shorter than 2–3 
 
m
 
m in length, although some-
what longer microtubules are occasionally seen as well. In
a small number of cells (
 
z
 
10%), significantly higher levels
of microtubule polymer are found throughout the cell
body, presumably because these cells correspond to those
in which the nocodazole treatment was less effective in de-
polymerizing microtubules. After 3 min of recovery, the
cells are then exposed to 50 nM vinblastine for various pe-
riods of time. By 15 min, the central region of the cell body
is empty or nearly empty of microtubules, with most of the
microtubules loosely packed at its periphery. By 30 min,
virtually all of the microtubules are tightly packed at the
periphery of the cell body. Most of the cells do not grow
axons, but in the small number that do, the outward pro-
gression of microtubules continues into the axons. In cells
examined at all points after the addition of vinblastine,
there is a variability in the length of the individual micro-
tubules that is generally similar to the variability observed
during the initial recovery from nocodazole. When the
microtubules redistribute from the centrosome, they some-
times tend to appear longer on average, but careful inspec-
tion suggests that this is due to the overlap of shorter mi-
crotubules. Quantitative analyses on microtubule mass
suggest that no microtubule assembly occurs in the pres- 
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ence of the vinblastine, and hence that the redistribution
of microtubules owes to microtubule transport (Ahmad
and Baas, 1995). To confirm that this conclusion is correct,
we have now performed studies to ascertain whether fluo-
rescent tubulin can incorporate into microtubules during
the vinblastine phase of this experimental regime.
Fig. 2, 
 
a
 
 and 
 
b
 
, shows a neuron treated with nocodazole,
rinsed free of the drug, immediately injected with fluores-
cent tubulin, and then prepared for immunofluorescence
visualization of microtubules 30 min later. The rhodamine
image (depicting fluorescent tubulin that had incorporated
into microtubule polymer; Fig. 2 
 
a
 
) and the fluorescein im-
age (immunofluorescence image of total microtubule
mass; Fig. 2 
 
b
 
) are similar in appearance, indicating com-
plete or near-complete incorporation of fluorescent tubu-
lin into polymer. This result was obtained with all 24 cells
treated in this fashion. Fig. 2, 
 
c
 
 and 
 
d
 
, show a neuron
treated with nocodazole, rinsed free of the drug, simulta-
neously exposed to 50 nM vinblastine and injected with
fluorescent tubulin (see Materials and Methods), and then
prepared for immunofluorescence visualization of micro-
tubules 30 min later. While the immunofluorescence im-
age shows the expected peripheral concentration of micro-
tubules (Fig. 2 
 
d
 
), the rhodamine image shows only faint
background fluorescence and a fluorescent “scar” made
by the injection (Fig. 2 
 
c
 
). No fluorescent microtubule
polymer was detected in this cell, or in any of the other 18
neurons treated in this fashion. On the basis of these re-
sults, we conclude that the 50 nM concentration of vinblas-
tine used in this regime is sufficient to inhibit microtubule
assembly from occurring over the time frame of the exper-
iment.
 
Microinjection of Recombinant Dynamitin Inhibits 
Cytoplasmic Dynein Function in Cultured Neurons
 
In previous studies, overexpression of dynamitin in non-
neuronal cells was shown to dissociate dynactin and inhibit
multiple forms of cytoplasmic dynein-based transport. This
resulted in mitotic arrest (Echeverri et al., 1996), mislocal-
ization of certain types of membranous organelles, and ab-
normalities in microtubule organization during interphase
(Burkhardt et al., 1997). To produce a similar but more
acute inactivation of cytoplasmic dynein function in the
present study, we have prepared and purified bacterially
expressed human dynamitin and microinjected it directly
into cultured rat sympathetic neurons. As a negative con-
trol, we microinjected cells with dynamitin preparations
that had been denatured by boiling. SDS-PAGE analyses
confirmed the purity of the protein preparations (Fig. 3 
 
a
 
).
Before studying the effects of the recombinant dynami-
tin on microtubule transport, we initially wished to confirm
in neurons the effects of the protein on a known function
of cytoplasmic dynein. Neurons are terminally postmitotic
cells, and for this reason we could not investigate its effects
on the formation or functioning of the mitotic spindle. How-
ever, neurons have a prominent Golgi apparatus located
near the nucleus at the center of the cell body, and several
lines of evidence indicate that the presence of a discrete
Golgi apparatus results from the transport of dispersed
Golgi elements along microtubules (Rogalski and Singer,
1984; Ho et al., 1989; Lococq et al., 1989) by cytoplasmic
dynein (Corthesy-Theulaz et al., 1992; Fath et al., 1994;
Burkhardt et al., 1997). Hence, the dispersion of the Golgi
apparatus can be used as a reliable indicator for the inacti-
vation of cytoplasmic dynein. To visualize the Golgi appa-
ratus, we used a fluorescent lectin that labels Golgi ele-
ments and, to a lesser extent, other membranes of the cell
(see Letourneau and Wire, 1995). We noted variable de-
grees of Golgi dispersion within the first few hours of dy-
namitin injection and dramatic and consistent Golgi dis-
persion by the sixth hour in over 50 cells analyzed in four
different experiments. Fig. 3 
 
b
 
 shows a typical cultured
neuron with a discrete Golgi apparatus located near the
nucleus. Fig. 3 
 
c
 
 shows a neuron 6 h after microinjection
with recombinant dynamitin; the Golgi apparatus is dis-
persed. The Golgi apparatus of cells injected with boiled
dynamitin protein was indistinguishable from that of unin-
jected control cells (not shown). These results indicate that
the viable dynamitin protein but not the denatured protein
disrupts a known function of cytoplasmic dynein function
in cultured neurons.
 
Recombinant Dynamitin Inhibits Axon Outgrowth
 
If microtubule transport is essential for establishing the
microtubule array of a developing axon, and if cytoplasmic
dynein is required for the transport of microtubules into
the developing axon, we would expect inhibition of cyto-
plasmic dynein function to be deleterious to axon out-
growth. To test this prediction, we measured the out-
growth of axons from uninjected neurons, neurons that
had been injected with the viable dynamitin protein, and
neurons that had been injected with the boiled protein.
The neurons were injected 30 min after plating, after they
had attached to the glass coverslip but before they had be-
Figure 1. Schematic illustration of our pharmacological strategy
for revealing the progression of microtubules outward from the
neuronal centrosome (Ahmad and Baas, 1995; see Results for de-
tails).  
Ahmad et al. 
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gun to grow axons. A total of at least 100 neurons were ex-
amined under each experimental condition. Uninjected
neurons and neurons injected with the boiled dynamitin
protein started to extend axons within the first hour of
plating, while the neurons injected with the viable dyna-
mitin protein showed no axon outgrowth during this time.
Neurons injected with the boiled dynamitin were slightly
slower to initiate axons than the uninjected cells, probably
because of the trauma of injection. (This same result was
obtained when buffer alone was injected.) The axons ex-
tended by the uninjected neurons and the neurons injected
with the boiled protein continued to grow, reaching lengths
exceeding hundreds of microns (370 ± 80 and 290 ± 60 
 
m
 
m,
respectively) by 7 h (Fig. 4 
 
a
 
). Immunofluorescence analyses
of these neurons showed intense staining for microtubules
in the cell bodies and axons (Fig. 4 
 
b
 
). By comparison, 109
of the 112 neurons injected with the native dynamitin pro-
tein showed either no axon outgrowth or substantially re-
duced levels of outgrowth even after 9 h, the longest time
at which they were observed. Three of the neurons ex-
tended axons similar in length to controls. Of the 109 neu-
rons that showed deleterious effects on axon outgrowth,
81 showed no axon outgrowth whatsoever (Fig. 4 
 
c
 
). These
cells extended only broad lamellipodia into which the micro-
tubules splayed but did not form dense bundles as they did
within the control axons (Fig. 4 
 
d
 
). Some of the dynamitin-
injected cells (28 of the 112) extended short processes with
a broad flat appearance, as opposed to the thin, cylindrical
appearance characteristic of control axons (Fig. 4 
 
e
 
). The
microtubules within these processes were more splayed
apart and less paraxial than those within the control axons
(Fig. 4 
 
f
 
). The average length of the processes extended by
these 109 dynamitin-injected neurons was 17 ± 5 
 
m
 
m, a re-
duction of 
 
z
 
95.5% compared with the uninjected neurons
and roughly a reduction of 94.1% compared with the neu-
rons injected with boiled protein. Thus excess recombinant
dynamitin resulted in a dramatic inhibition of axon outgrowth
in over 97% of the cells into which it was microinjected.
Figure 2. Evidence that the
pharmacological strategy re-
veals microtubule transport,
not microtubule assembly. a
and b show a neuron treated
with nocodazole, rinsed free
of the drug, immediately
injected with fluorescent
tubulin, and then prepared
for immunofluorescence vi-
sualization of microtubules
30 min later. The rhodamine
image (depicting fluorescent
tubulin that had incorpo-
rated into microtubule poly-
mer [a]) and the fluorescein
image (immunofluorescence
image of total microtubule
mass [b]) are similar in ap-
pearance, indicating complete
or near-complete incorpora-
tion of fluorescent tubulin
into polymer. c and d show a
neuron treated with nocoda-
zole, rinsed free of the drug,
simultaneously exposed to 50
nM vinblastine, injected with
fluorescent tubulin (see Ma-
terials and Methods), and
then prepared for immuno-
fluorescence visualization of
microtubules 30 min later.
The immunofluorescence im-
age shows the expected pe-
ripheral concentration of mi-
crotubules (d). The rhodamine
image shows only faint back-
ground fluorescence and a
fluorescent “scar” made by
the injection (c). No fluores-
cent microtubule polymer was
detected. Bar, 5 mm. 
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Recombinant Dynamitin Inhibits the Outward 
Progression of Microtubules from the Centrosome
 
The inhibition of axon outgrowth that we observed in cells
injected with the recombinant dynamitin is consistent with
the hypothesis that cytoplasmic dynein is required for mi-
crotubule transport into the axon. However, inhibition of
axon outgrowth is also consistent with the inactivation of
other known functions of the motor. For example, cyto-
plasmic dynein is known to function in the retrograde trans-
port of endocytosed materials, such as growth factors that
are essential for axon growth. Therefore, to test whether
cytoplasmic dynein is necessary for the transport of micro-
tubules, we needed to use an assay for microtubule trans-
port that is independent of axon outgrowth or other known
functions of the motor. Toward this end, we used the phar-
macological assay described above. 
Neurons that had been microinjected with the boiled dy-
namitin protein (Fig. 5) exhibited the same microtubule
behaviors that we previously observed in uninjected neu-
rons. 3 min after nocodazole removal, a dense radial array
of short microtubules was apparent at the centrosome
(Fig. 5 
 
a
 
). A few unattached microtubules of roughly the
same length were also sometimes apparent. In the cell
shown in Fig. 5 
 
a
 
, the microtubules are 1–2.5 
 
m
 
m in length,
but sometimes these lengths were as long as 
 
z
 
5 
 
m
 
m. After
exposure to 50 nM vinblastine for 15 min, microtubules
were essentially absent from the central region of the cell
body and became loosely packed near its periphery (Fig. 5 
 
b
 
).
Note that the microtubules in the cell shown in Fig. 5 
 
b
 
 are
slightly longer than those shown in Fig. 5 
 
a
 
, but they are
not outside of the range of microtubule lengths identified
in other cells before vinblastine treatment. After 30 min
in vinblastine, the microtubules were also at the cell pe-
riphery but were now more tightly packed (Fig. 5 
 
c
 
). In 50
cells examined at each of these time points, all of the cells
showed this peripheral concentration of microtubules.
Only two cells at each time point failed to show the ab-
sence or near absence of microtubules from the central re-
gion of the cell body. At times exceeding 1 h, some of the
cells extended short axons, and in these cases, the microtu-
bules continued to vacate the cell body as they began to
appear within the axons (data not shown). Though the mi-
crotubule nucleating center was usually centrally located,
it could also sometimes be found near the edge of the cell,
as was the case with the neuron shown in Fig. 5 
 
a
 
.
By contrast with control cells, neurons that had been mi-
Figure 3. SDS-PAGE gel showing the purity of the recombinant
dynamitin preparations (a) and micrographs showing Golgi dis-
tribution in a control neuron (b) and a neuron 6 h after microin-
jection with recombinant dynamitin (c). a shows Coomassie blue
staining of native (lanes 1 and 3) and boiled (lanes 2 and 4) dyna-
mitin preparations purified either by nickel-affinity (lanes 1 and
2) or by two-step chromatography (lanes 3 and 4). The analyses
confirm the presence of a single major band of the expected size,
50 kD, common to both preparations. In b, the control neuron
shows a discrete Golgi apparatus located near the nucleus. In c,
the Golgi elements are dispersed throughout the injected cell.
Bar, 5 mm.
Figure 4. Effects on axon
outgrowth of recombinant
dynamitin. (a) A neuron 7 h
after plating. Hundreds of mi-
crons of axons have grown.
(b) An immunofluorescence
image showing the dense mi-
crotubule array of the same
cell after extraction and fixa-
tion. (c) A typical neuron 9 h
after microinjection with the
recombinant dynamitin. The
cell has extended a broad
lamellipodium but no axons.
(d) An immunofluorescence
image of the microtubule ar-
ray within this cell. The mi-
crotubules splayed into the
lamellipodia but did not form dense bundles as they did within the axons of control neurons.  (e) One of a small number of neurons in-
jected with recombinant dynamitin that extended processes (shown 9 h after microinjection). In these cases, the processes were signifi-
cantly shorter than the axons of control neuron and also had a broad flat appearance that was rather different from the thin cylindrical
shape of the control axons.  (f) An immunofluorescence image of the microtubule array within this cell. The microtubules within these
processes are more spayed apart and less paraxial than those within the control axons. Bar, 10 mm. 
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croinjected with the native dynamitin protein showed dif-
ferences in microtubule organization at all stages of the
experimental regime after microinjection, even after the
initial 3-min recovery from nocodazole. In some of the cells,
the individual microtubules emanating from the centrosome
had somewhat greater lengths than those within corre-
sponding control cells (Fig. 6 
 
a
 
). This is reminiscent of sim-
ilar observations on mitotic nonneuronal cells induced to
overexpress dynamitin (Echeverri et al., 1996; our unpub-
lished data), and also of recent observations of abnormally
elongated cytoplasmic microtubules in dynein-deficient
yeast (Carminati and Stearns, 1997). In other cells, the nu-
cleating center appeared somewhat more diffuse than in
similarly treated control cells (Fig. 6 
 
b
 
), also reminiscent of
similar observations in dynamitin-overexpressing nonneu-
ronal cells (Burkhardt et al., 1997). Some of the dyna-
mitin-injected neurons displayed somewhat lower appar-
ent levels of microtubule polymer than control cells
recovered for the same amount of time, even though indi-
vidual microtubules within these same cells may have been
somewhat longer than those in control cells (compare for
example the cell shown in Fig. 6 
 
a
 
 with the cell shown in
Fig. 5 
 
a
 
). For this reason, we increased the recovery time
from 3 to 7.5 min to obtain microtubule levels that were
more consistently similar to the levels obtained in control
cultures recovered for 3 min.
Neurons incubated in vinblastine for 15 or 30 min after
introducing the recombinant dynamitin and rinsing out the
nocodazole were markedly different from similarly treated
control neurons with regard to microtubule distribution.
Over 70 neurons were analyzed at each of these time
points. At both time points, approximately half of the cells
showed microtubules still clustered at their apparent nu-
cleation sites (Figs. 7, 
 
a
 
 and 
 
b
 
, and 8, 
 
a
 
 and 
 
b
 
), while the
other half showed microtubules distributed throughout their
cytoplasm (Figs. 7 
 
c
 
 and 8, 
 
c
 
 and 
 
d
 
). In the former group,
the apparent nucleation sites were located closer to the
edge of the cell than to its center. In addition, most of the
apparent nucleation sites had the somewhat more diffuse
appearance mentioned above (Figs. 7 a and 8, a and b). In
some neurons, the nucleation site had completely split into
two relatively discrete and spatially segregated sites (Fig. 7 b).
Most importantly, in no case did we observe the character-
istic peripheral concentration and corresponding depletion
of microtubules from cell center observed in comparable
uninjected cells or cells injected with the boiled protein.
Thus, inhibition of cytoplasmic dynein function by recom-
binant dynamitin inhibits the outward progression of mi-
crotubules from the neuronal centrosome.
Discussion
The present study represents the latest in our ongoing ef-
forts to understand the mechanisms by which the axonal
microtubule array is established. There are essentially two
schools of thought on this issue, one based on the active
Figure 5. Neurons at various
stages of the pharmacologi-
cal regime designed to re-
veal the outward progres-
sion of microtubules from
the centrosome. The cells
shown here were injected
with the boiled recombinant
dynamitin before rinsing out
the nocodazole (see Results
for details). The results were
indistinguishable from those
obtained on uninjected cells.
(a) A neuron that had been treated with nocodazole, microinjected with the boiled protein, rinsed free of the drug for 3 min, and then
prepared for immunofluorescence visualization of microtubules. A dense radial array of short microtubules is apparent at the cen-
trosome, as are a few unattached microtubules of roughly the same length.  (b) A neuron treated in similar fashion and then exposed to
50 nM vinblastine for 15 min. Microtubules are essentially absent from the central region of the cell body and are loosely packed be-
neath its periphery.  (c) A neuron exposed to vinblastine for 30 min. The microtubules are more tightly packed at cell periphery. The mi-
crotubules vary somewhat in length from cell to cell, with some of the microtubules appearing longer in the cell shown in b than those in
the cell shown in a. However, the differences are no greater than those observed among different cells before or after vinblastine treat-
ment. Bar, 3 mm.
Figure 6. Examples of neurons treated with nocodazole, injected
with recombinant dynamitin, rinsed free of the drug for 3 min,
and then immunostained to reveal microtubules.  (a) A neuron
with a discrete site of nucleation similar to control neurons. The
microtubules are fewer and somewhat longer than the microtu-
bules in similarly treated control neurons.  (b) A neuron in which
the site of nucleation is somewhat more diffuse than in a similarly
treated control (uninjected or injected with boiled dynamitin pro-
tein) neuron, but the level of microtubule reassembly is similar.
Small white arrows indicate the perimeter of the cell body where
it is not apparent from the immunofluorescence image. Bar, 3 mm.The Journal of Cell Biology, Volume 140, 1998 398
transport of microtubules, and the other based on the con-
cept of stationary microtubules (for reviews see Baas and
Brown, 1997; Hirokawa et al., 1997). Results from our lab-
oratory support the first idea and suggest a model whereby
microtubules destined for the axon are nucleated and then
released from the centrosome within the cell body of the
neuron, after which they are actively transported into the
axon by a microtubule-based motor protein. A technical
challenge in testing this model is distinguishing the contri-
bution of microtubule transport from that of microtubule
assembly. To accomplish this, two recent studies from our
laboratory have used the pharmacological agent vinblas-
tine to suppress microtubule assembly and thereby reveal
the contribution of microtubule transport. In the first of
these studies, we demonstrated that neurons cultured in
the presence of nanomolar levels of vinblastine continue
to grow axons, and that microtubules accumulate within
the axons while concomitantly vacating the cell body (Baas
and Ahmad, 1993). In the second study, a nocodazole-
recovery regime was used to obtain a synchronized burst
of microtubules from the centrosome before exposing the
neurons to vinblastine. After the addition of vinblastine,
we documented an outward progression of the microtu-
bules from the centrosome into the axon (Ahmad and
Baas, 1995). These results were interpreted in terms of the
active transport of microtubules.
Our interpretation of these results has recently been
challenged by Miller and Joshi (1996), who questioned
whether the vinblastine treatments used in our studies
were actually effective in suppressing microtubule assembly.
These authors exposed cultured neurons to vinblastine, in-
jected them with fluorescent tubulin, waited various peri-
ods of time, extracted them to remove free tubulin, and
then determined whether any of the fluorescent tubulin
had incorporated into microtubule polymer. They found
that vinblastine concentrations of 1 or 4 nM permitted flu-
orescent tubulin to incorporate into polymer segments
that grew by fractions of a micron per minute. However,
they did not determine whether the incorporation of fluo-
rescent tubulin represents the net assembly of new micro-
tubule polymer or merely subunit exchange with the solu-
ble tubulin pool. It is well documented that vinblastine
does not entirely inhibit microtubules from exchanging sub-
units with the soluble tubulin pool, even when used at con-
centrations sufficient to suppress the addition of new poly-
mer (Wilson and Jordan, 1994; Ahmad and Baas, 1995;
Figure 7. Examples of neu-
rons treated with nocoda-
zole, injected with recombi-
nant dynamitin, rinsed free
of drug for 7.5 min, exposed
to vinblastine for 15 min, and
then immunostained to re-
veal microtubules. In no such
case did the microtubules va-
cate the central region of the
cell body and concentrate be-
neath the cell periphery, as
was the case with similarly
treated uninjected neurons or neurons injected with boiled protein.  (a) A neuron in which most of the microtubules remained attached
to their apparent nucleation site, which had become rather diffuse in appearance. (b) A neuron in which the nucleation site had split
into two, and most of the microtubules remained attached to these sites. A few unattached microtubules were present at cell periphery,
but the vast majority were not.  (c) A neuron in which the microtubules were dispersed throughout the cytoplasm and not attached to
any apparent nucleation sites. Small white arrows indicate the perimeter of the cell body where it is not apparent from the immunofluo-
rescence image. Bar, 4 mm.
Figure 8. Examples of neurons treated with nocodazole, injected
with recombinant dynamitin, rinsed free of drug for 7.5 min, and
then exposed to vinblastine for 30 min. In no such case did the
microtubules vacate the central region of the cell body and con-
centrate beneath the cell periphery, as was the case with similarly
treated uninjected neurons or neurons injected with boiled pro-
tein. (a and b) Neurons in which some of the microtubules appear
to be attached to a rather diffuse nucleation site. Other microtu-
bules were dispersed. (c and d) Neurons in which the microtu-
bules do not appear to be attached to discernible nucleation sites,
but rather appear to be dispersed throughout the cytoplasm. Flu-
orescence intensity is saturating within the densest cluster of mi-
crotubules in b. Small white arrows indicate the perimeter of the
cell body where it is not apparent from the immunofluorescence
image. Bar, 4 mm.Ahmad et al. Cytoplasmic Dynein Transports Microtubules into the Axon 399
Tanaka et al., 1995; for more discussion see Baas, 1997;
Baas and Brown, 1997). Moreover, Miller and Joshi did
not use the 50 nM vinblastine concentration used in our
studies, nor did they use our specific experimental regime.
In the present study, we have established that no detect-
able fluorescent tubulin incorporates into microtubule
polymer in our experimental regime using the 50 nM vin-
blastine concentration. As suggested above, if fluorescent
tubulin had incorporated into the microtubules, this would
not have proven that any consequential microtubule as-
sembly occurred in the presence of the drug. However, the
fact that there was little or no incorporation shows unequi-
vocally that our results cannot be attributed to microtu-
bule assembly. Thus, as originally concluded, the outward
progression of microtubules observed with our regime must
be the result of microtubule transport. 
If microtubule transport plays such a key role in orga-
nizing neuronal microtubules, then what is the role of the
centrosome? In many cell types the centrosome anchors
the microtubules at their minus ends, resulting in a radial
array of uniformly oriented microtubules (for review see
Brinkley, 1985). With regard to neurons and other cell types
that establish microtubule arrays at sites distal to the cen-
trosome, we have suggested that the centrosome acts as a
kind of “generator” of microtubules, nucleating them with
the proper lattice structure and then releasing them for
transport into other regions of the cell (Baas, 1996). In
support of this view, sophisticated templates for microtu-
bule nucleation have now been identified within the peri-
centriolar material. These templates consist of g-tubulin to
nucleate the microtubule, in combination with several other
proteins that form ring structures ideally suited to con-
strain its lattice structure (Moritz et al., 1995; Zheng et al.,
1995). In addition, a novel protein called katanin has been
localized in at least one cell type to a region just outside of the
pericentriolar material (McNally et al., 1996). Katanin is a
microtubule-severing protein, and its distribution around
the pericentriolar material can readily explain how a mi-
crotubule is released so that it can be transported away
from the centrosome. Thus, the machinery exists within
cells to release centrosomal microtubules, and it is provoc-
ative to speculate that microtubule release may be more
active in cell types that must deploy their microtubules. In
strong support of this view, Keating and colleagues (1997)
have now directly observed microtubule release and trans-
port from the centrosome of living epithelial cells, close
cousins to the neuron.
Cytoplasmic Dynein and Microtubule Transport
The main goal of the present studies was to test the hy-
pothesis that cytoplasmic dynein is the motor protein that
transports microtubules from the neuronal centrosome
into the axon. Cytoplasmic dynein is a molecular motor
that translocates toward the minus end of the microtubule.
Assuming that the motor is tethered to another structure
with greater resistance to movement than the microtubule
itself, cytoplasmic dynein would have the appropriate
properties to transport microtubules with their plus ends
leading away from the centrosome. Our analyses, using an
excess of dynamitin to inhibit cytoplasmic dynein function,
indicate that the redistribution of microtubules from the
neuronal centrosome depends on the activity of this mo-
tor. When cytoplasmic dynein function is inhibited, the mi-
crotubules are not conveyed to cell periphery but instead
remain near the centrosome or dispersed throughout the
cytoplasm of the neuron. These results provide an addi-
tional line of evidence indicating that motor-driven trans-
port is the means by which microtubules relocate from the
neuronal centrosome, and also demonstrate that cytoplas-
mic dynein and the dynactin complex are essential compo-
nents of the molecular machinery by which this transport
occurs.
There is an additional component of the transport ma-
chinery that our studies have not addressed, namely the
structures or “substrate” against which cytoplasmic dynein
generates its forces. As the motor domain of the molecule
interacts with the microtubule, the cargo domain interacts
via dynactin with another structure in the cytoplasm such
as a membranous element, another type of cytoskeletal el-
ement, or another microtubule. If the microtubule is im-
mobilized (for example by its attachment to the centro-
some), then this other structure will be transported toward
the minus end of the microtubule. However, as noted
above, if the microtubule is not tethered to the centro-
some, and if the other structure has a greater resistance to
movement, then it is the microtubule itself that will be
transported. One possibility is that the released microtu-
bules are transported relative to the same kinds of mem-
branous organelles that move toward the minus ends of
microtubules that are attached to the centrosome. When
the microtubule is attached to the centrosome, it has the
greater resistance to movement, but when the microtubule
is released, the organelles have a greater resistance to
movement, and the microtubule moves toward cell periph-
ery. Thus, the redistribution of microtubules and the direc-
tion of microtubule transport reported here may be a sim-
ple manifestation of the activity of cytoplasmic dynein and
the conservation of momentum. A related possibility is
that the microtubules are transported relative to one spe-
cific membranous structure, such as the extensive network
of endoplasmic reticulum within the neuron (see Baas and
Brown, 1997).
A very different possibility is that microtubules are trans-
ported away from the centrosome by generating forces
against other cytoskeletal elements within the neuron. In
the recent studies of Heald and collaborators (1996), short
microtubules were observed to move relative to longer mi-
crotubules during the formation of artificial microtubule
spindles in vitro. However, in these studies, the short mi-
crotubules moved with minus ends leading toward the mi-
nus ends of the longer microtubules, indicating that the
short microtubules were conveyed as cargo. In our studies,
it is unlikely that individual microtubules move by gener-
ating forces against one another because their transport is
quite efficient even at relatively low microtubule densities.
In addition, most of the microtubules are roughly similar
in length, and none appear to be immobilized. Thus it is
difficult to imagine how forces could be generated be-
tween microtubules to translocate virtually the entire mi-
crotubule mass from the center of the cell to its periphery.
A more likely possibility is that the microtubules are mov-
ing relative to the actin-based cytomatrix. This idea was
first proposed several years ago (McQuarrie et al., 1986)The Journal of Cell Biology, Volume 140, 1998 400
and is supported by recent studies showing that cytoplas-
mic dynein and dynactin are anterogradely transported
down the axon at the same rate as the actin-based cytoma-
trix (Dillman et al., 1996a,b). On this basis, the Pfister lab-
oratory has proposed that cytoplasmic dynein interacts via
dynactin with the actin filaments that move down the
axon, leaving the motor domain of the dynein molecule
available to transport microtubules. The fact that the mi-
crotubules are transported somewhat more slowly than
the actin filaments probably owes to an intermittent asso-
ciation of microtubules with the motor complex. A poten-
tial concern with this model is raised by studies showing
that actin and dynactin do not directly interact (Holleran
et al., 1996). However, it is possible that an indirect inter-
action between actin and dynactin is mediated by yet an-
other protein, such as fodrin (see McQuarrie et al., 1986).
There are other reasons why a model invoking the actin
cytomatrix is potentially attractive. Over the years, there
have been several lines of evidence suggesting that micro-
tubules and actin filaments are functionally linked in some
way (for review see Gavin, 1997). One possibility is that
force generation between these two polymer systems by
cytoplasmic dynein is a common theme across cell types
that is exaggerated in the neuron. Some support for this
idea derives from the fact that disrupting actin filaments
with drugs such as cytochalasin and disrupting cytoplasmic
dynein function appear to have many of the same effects on
microtubules. In both cases, there can be notable changes in
tension on the microtubules as well as abnormal increases
in microtubule length (Echeverri et al., 1996; Heidemann,
1996; Carminati and Stearns, 1997; Gavin, 1997; our
present results). In addition, it is not difficult to imagine
how the actin cytomatrix could confer directionality on the
transport of microtubules. Like microtubules, actin fila-
ments are polar structures, and the progression of microtu-
bules outward from the centrosome might be the result of
the polarity orientation of the actin filaments. Alterna-
tively, the microtubules may move outward because the
actin cytomatrix is denser near the cell membrane. In sup-
port of this view, studies on nematode axons have shown
that the distal ends of the microtubules tend to tilt off the
longitudinal axis toward the cell membrane (Chalfie and
Thompson, 1979). 
The past few years have seen a revolution with regard to
the role of molecular motor proteins in organizing micro-
tubules. While early work focused on the role of motor
proteins in transporting membranous elements along mi-
crotubules, it is now clear that motor proteins also play
fundamental roles in organizing microtubules themselves.
For example, there is abundant evidence that cytoplasmic
dynein and a variety of kinesin-related motor proteins are
essential for the formation and functioning of the mitotic
spindle, the most fundamental of all microtubule arrays
(for review see Barton and Goldstein, 1996). Studies from
our laboratory indicate that postmitotic neurons do not
abandon the principles that underlie microtubule organi-
zation within dividing cells. For example, we have shown
that the kinesin-related protein known as CHO1/MKLP1,
previously thought to be mitosis-specific, continues to be
expressed in postmitotic neurons, where it plays a key role
in transporting microtubules into the dendrite (Sharp et al.,
1997). The present studies on cytoplasmic dynein demon-
strate that at least one other motor has critical roles in or-
ganizing microtubules both in the mitotic spindle and in
the postmitotic neuron. We would conclude that the trans-
port of microtubules by motor proteins such as cytoplas-
mic dynein is a theme used across cell types, and that neu-
rons capitalize on this theme to elaborate their elongate
processes.
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